Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
4d
Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira
AbbVie holds a strong portfolio of marketed and pipeline drugs. While the increasing competition to the company's key drug Humira should slow the growth for the company in the near term, we believe ...
5d
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Iran launches missile attack
FL homeless law kicks in
Helene wreaks havoc
How to watch VP debate
'Good Times' star dies
Pledges support for Ukraine
GA abortion ban blocked
Broadway star dies at 70
US job openings rebound
Breast cancer deaths fall
Tulsa Race Massacre probe
TX fraud probe shut down
Kentucky sheriff steps down
Asylum restrictions extended
Arkansas sues YouTube
Explosive devices found
Court reinstates Indiana suit
Wausau drop box replaced
Files for bankruptcy
Top Adams aide resigns
US sanctions settler group
To tour Helene devastation
194K Jeep SUVs recalled
120 new assault allegations
'Pled guilty to journalism'
Jimmy Carter turns 100
Settlement checks delayed
CA sues Catholic hospital
Feedback